Bioceres Crop Solutions (BIOX) Current Deferred Revenue (2017 - 2026)

Bioceres Crop Solutions has reported Current Deferred Revenue for 10 years, with the latest figure at $2.8 million in Q1 2026.

• Quarterly Current Deferred Revenue fell 27.5% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 27.5% YoY) and the FY2025 annual result came in at $4.3 million, up 9.61% from the prior year.
• Current Deferred Revenue climbed to $2.8 million in Q1 2026 per BIOX's latest filing, from $2.5 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $44.1 million in Q4 2022 and troughed at $2.3 million in Q3 2025.
• A 5-year average of $12.0 million and a median of $5.5 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue jumped 1086.28% in 2023, then slumped 86.74% in 2024.
• Over 5 years, Current Deferred Revenue stood at $44.1 million in 2022, then slumped by 49.93% to $22.1 million in 2023, then plunged by 86.74% to $2.9 million in 2024, then decreased by 14.73% to $2.5 million in 2025, then advanced by 12.09% to $2.8 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.8 million, $2.5 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.